Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

venetoclax 28Rituximab 22ibrutinib 21acalabrutinib 21Cyclophosphamide 20Specimen Handling 18obinutuzumab 15Biopsy 14fludarabine 13zanubrutinib 10pirtobrutinib 10fludarabine phosphate 9Magnetic Resonance Spectroscopy 8Bendamustine Hydrochloride 8idelalisib 6Whole-Body Irradiation 6Mycophenolic Acid 6Lenalidomide 6CT-P10 6ARQ531 6Cyclosporine 5Sirolimus 4Peripheral Blood Stem Cell Transplantation 4pembrolizumab 3Vincristine 3Tacrolimus 3Prednisone 3Doxorubicin 3Disulfides 3Cyclosporins 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Lymphocytic, Chronic, B-Cell × Chlorambucil × 90 days × Clear all
NCT03462719 2026-05-08

GLOW

Janssen Research & Development, LLC

Phase 3 Active not recruiting
211 enrolled 23 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡